Flinders cancer experts have been awarded a major $553,196 grant to improve the survival and recovery of colorectal cancer patients via a simple blood test. Chief […]
Tens of thousands are likely to be saved by an early blood test for recurrent bowel cancer – a test case in commercialisation of Australian research. […]
Pioneering cancer research at Flinders has led to development of a new blood test called Colvera, which is in the shortlist for a national Eureka science […]
After 20 years of research by Flinders medical researchers, a new sports hydration drink called PREP’D is poised to be a super boost for athletes and […]
A new blood test targeting tumor DNA in colorectal (bowel) cancer patients has detected early signs of recurrence of the disease at twice the rate of […]
Flinders is leading a global research effort to find a low-cost way to use a dietary technique to reduce infant mortality rates in low-income countries including Africa and India.
Dementia, bowel cancer and glaucoma are among diseases to be addressed by researchers at Flinders with National Health and Medical Research Council funding of nearly $5.1 million.
South Australian Scientist of the Year Professor Graeme Young is calling for more investment on the implementation of existing medical research findings and knowledge.
A team of Australian scientists has presented evidence that a new blood test for bowel cancer based on two genes that “leak” into the blood can detect 65 per cent of bowel cancer cases.